IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
1-Year Return
17.25%
This Quarter Return
+5.7%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$379M
AUM Growth
+$697K
(+0.18%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-3.84%
Top 10 Holdings %
Top 10 Hldgs %
54.1%
Holding
70
New
14
Increased
14
Reduced
8
Closed
4
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$6.81M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$6.23M |
| 3 |
Incyte
INCY
|
$4.95M |
| 4 |
Harmony Biosciences
HRMY
|
$4.69M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$3.81M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$16M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$14.5M |
| 3 |
Exelixis
EXEL
|
$14.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.16M |
| 5 |
Illumina
ILMN
|
$6.26M |
Sector Composition
| 1 | Healthcare | 98.93% |
